Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option Post author:Sam Post published:April 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017 August 2, 2017 Outrage Leads Senator to Draft Bill in Response to Allergan's 'Should-be-Illegal' Patent Maneuver October 5, 2017 Glytec LLC Release: New Research Further Validates Benefits Of Personalized Diabetes Therapy Management Across The Continuum Of Care February 15, 2017
Outrage Leads Senator to Draft Bill in Response to Allergan's 'Should-be-Illegal' Patent Maneuver October 5, 2017
Glytec LLC Release: New Research Further Validates Benefits Of Personalized Diabetes Therapy Management Across The Continuum Of Care February 15, 2017